- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 09.06. | Sharps Technology Inc: Sharps Technology CEO, Robert Hayes, to Present at the Virtual Investor Summit on June 10, 2025 | 4 | GlobeNewswire (USA) | ||
| 04.06. | Aktie von Sharps Technology steigt nach ersten kommerziellen Lieferungen | 1 | Investing.com Deutsch | ||
| 04.06. | Why Is Sharps Technology Stock Soaring On Wednesday? | 4 | Benzinga.com | ||
| 04.06. | Sharps Technology stock soars on first commercial shipments | 4 | Investing.com | ||
| 04.06. | Pre-market Movers: Baosheng Media, Sharps Technology, New Century Logistics, NewGenIvf Group, Bon Natural Life | 429 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.35 A.M. ET).In the Green Baosheng Media Group Holdings Limited (BAOS) is... ► Artikel lesen | |
| SHARPS TECHNOLOGY Aktie jetzt für 0€ handeln | |||||
| 04.06. | Sharps Technology Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 04.06. | Sharps Technology Inc: Sharps Technology Begins Shipments Across Three Customer Orders Under Previously Announced Purchase Agreements | 2 | GlobeNewswire (USA) | ||
| 22.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.05. | Sharps Technology regains compliance with Nasdaq's listing rules | 1 | Seeking Alpha | ||
| 22.05. | Sharps Technology Inc: Sharps Technology Regains Compliance with Nasdaq Minimum Bid Price Listing Rule | 138 | GlobeNewswire (Europe) | NEW YORK, May 22, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (Nasdaq: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 15.05. | Sharps Technology Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 07.05. | Sharps Technology Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 30.04. | Pre-market Movers: Regulus Therapeutics, Jeffs' Brands, INVO Fertility, GeneDx Holdings, Sharps Technology | 731 | AFX News | TEMPE (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Regulus Therapeutics Inc. (RGLS) is up over 132%... ► Artikel lesen | |
| 30.04. | Sharps Technology Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.04. | Sharps Technology receives $400K initial purchase order | 1 | Seeking Alpha | ||
| 24.04. | Sharps Technology announces 1-for-300 reverse stock split; shares down | 6 | Seeking Alpha | ||
| 24.04. | Sharps Technology Inc: Sharps Technology Announces Reverse Stock Split | 656 | GlobeNewswire (Europe) | NEW YORK, April 24, 2025 (GLOBE NEWSWIRE) -- Sharps Technology, Inc. (NASDAQ: "STSS" and "STSSW") ("Sharps"), an innovative medical device and pharmaceutical packaging company offering patented, best-in-class... ► Artikel lesen | |
| 15.04. | Sharps Technology Inc. - 10-K/A, Annual Report | 3 | SEC Filings | ||
| 14.04. | Sharps Technology Inc. - 8-K, Current Report | 7 | SEC Filings | ||
| 04.04. | Sharps Technology Inc. - 8-K, Current Report | 9 | SEC Filings |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| STRATEC | 27,000 | +0,19 % | STRATEC zieht wieder auf dem Parkett ein | Am 9. Mai war STRATEC wegen nicht rechtzeitig erfolgter Vorlage des testierten Jahresabschlusses aus dem SDX entfernt worden. Und nun, dank des Rückzugs des Softwareanbieters COMPUGROUP von der Börse... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,105 | -1,87 % | Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair | LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,704 | -5,38 % | Atossa Therapeutics, Inc.: Join Atossa Therapeutics' Exclusive Live Investor Webinar and Q&A Session on May 22 | SEATTLE, WASHINGTON / ACCESS Newswire / May 20, 2025 / Atossa Therapeutics, Inc. (Nasdaq:ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing innovative medicines... ► Artikel lesen | |
| PING AN HEALTHCARE | 0,946 | +9,49 % | PA GOODDOCTOR (01833): POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 26 JUNE 2025 | ||
| MOUNTAIN VALLEY MD | 0,002 | -50,00 % | Mountain Valley MD Holdings Inc: Mountain Valley hopes for continued growth in 2025 | ||
| CO-DIAGNOSTICS | 0,208 | -3,70 % | Co-Diagnostics, Inc. Reports Full Year 2024 Financial Results | SALT LAKE CITY, March 27, 2025 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the... ► Artikel lesen | |
| CYTOSORBENTS | 0,981 | -1,70 % | Cytosorbents Corp: CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb-ATR | PRINCETON, N.J., June 24, 2025 /PRNewswire/ -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive... ► Artikel lesen | |
| VERU | 0,554 | -0,90 % | Veru Inc.: Veru Reports Positive Results from Phase 2b QUALITY and Maintenance Extension Study Showing Enobosarm Significantly Reduced Body Weight Regain, Prevented Fat Regain, and Preserved Lean Mass After Semaglutide Discontinuation | --During the Maintenance Period of 12 weeks after discontinuing semaglutide (GLP-1 receptor agonist), placebo group regained 43% of body weight that was previously lost during Phase 2b QUALITY study... ► Artikel lesen | |
| TEMPEST THERAPEUTICS | 6,010 | -100,00 % | Tempest Therapeutics: Tempest Reports First Quarter 2025 Financial Results and Provides Business Update | Presented new amezalpat mechanism-of-action data reinforcing its potential as a novel cancer treatment at the 2025 AACR Annual MeetingGranted Orphan Drug designation by FDA for TPST-1495 for the treatment... ► Artikel lesen | |
| VOLITIONRX | 0,750 | 0,00 % | VOLITIONRX LTD - 8-K, Current Report | ||
| EKSO BIONICS | 3,600 | 0,00 % | XFRA 23E0: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILEKSO BIONICS. NEW... ► Artikel lesen | |
| IMUNON | 0,675 | -1,46 % | H.C. Wainwright reiterates buy rating on Imunon stock at $14 target | ||
| BEYOND AIR | 0,146 | +3,55 % | Beyond Air-Aktionäre genehmigen Reverse-Aktiensplit | ||
| AVINGER | 0,340 | -6,08 % | NSE - Avinger Inc - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | ||
| NOVACYT | 0,479 | +4,59 % | Novacyt S.A. - Result of AGM |
SHARPS TECHNOLOGY INC gehört der Branche Gesundheitswesen an. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 5,510 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu SHARPS TECHNOLOGY INC finden Sie auf Wallstreet Online.